Berlin-based Ada Health, a company that helps diagnose symptoms and offer treatment advice using an AI-enabled platform, announced on Thursday that it has raised $30M (approx €26.21M) in its Series B extension round.
This comes after an initial Series B raise of $90M in May, 2021, which was led by Leaps by Bayer, the impact investment arm of Bayer AG, with further investments from Vitruvian Partners, Inteligo Bank, F4, and Mutschler Ventures.
The company was founded in 2011 by doctors, scientists and industry pioneers to create new possibilities for personal health. Its founders include Claire Novorol, Daniel Nathrath and Martin Hirsch.
Ada connects medical knowledge with technology to help people actively manage their health by working with leading health providers and organisations. The platform has more than 12 million users globally and has completed over 26.5 million assessments since its global launch in 2016.
In November 2019, the company had launched a Swahili language version of its assessment app to offer medical information to users and expand its services in East Africa. Currently, the company offers about seven different languages on its app.